4//SEC Filing
Frias Juan Pablo 4
Accession 0000950170-23-046099
CIK 0001840439other
Filed
Aug 31, 8:00 PM ET
Accepted
Sep 1, 5:10 PM ET
Size
5.5 KB
Accession
0000950170-23-046099
Insider Transaction Report
Form 4
Frias Juan Pablo
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-08-31+300,000→ 300,000 totalExercise: $16.87Exp: 2033-08-30→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]One-sixteenth (1/16th) of the total number of shares subject to the stock option shall vest and become exercisable at the end of the third month following August 31, 2023 and one-sixteenth (1/16th) of the total number of shares subject to the stock option shall vest and become exercisable quarterly thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Documents
Issuer
Biomea Fusion, Inc.
CIK 0001840439
Entity typeother
Related Parties
1- filerCIK 0001990665
Filing Metadata
- Form type
- 4
- Filed
- Aug 31, 8:00 PM ET
- Accepted
- Sep 1, 5:10 PM ET
- Size
- 5.5 KB